Cancer BiologybioRxiv
BRG1 is a prognostic indicator and a potential therapeutic target for prostate cancer
R. Muthuswami, L. Bailey, R. Rakesh…·J. W. Hockensmith
This study shows BRG1 is elevated in prostate tumors and correlates with poor survival, and a BRG1 inhibitor reduces tumor growth and improves survival in xenograft models.
DOI 10.1002/jcp.28161